'Multidisciplinary teams are crucial for the treatment of ILD."
'Multidisciplinary teams are crucial for the treatment of ILD."
'I'm very passionate about unravelling ILD'
'Every country should have a reference centre for ILD'
‘The care and research of ILD is really a joined effort’
'We hope to make the lives of ILD-patients a little more comfortable'
'Meeting fellow-sufferers can mean a lot for ILD-patients'
Acid reflux and idiopathic pulmonary fibrosis: the search for definitive answers
ILD and lung cancer: an unfortunate combination of events
Urgent need for action to prevent ILD caused by marine engines
Non-quartz part of coal might turn the coalminer's lungs to black
‘Lung on a chip’: the solution for testing lung-medicine?
Antifibrotics may help IPF patients waiting for a lung transplantation
IPF: the importance of early identification and a multidisciplinary approach
Sarcoidosis: a riddle to unfold
Improving palliative care for IPF patients
'Protect roadworkers against lung damage from asphalt fumes'
'Support the people that support the patients'
'Why keep smoking when you suffer from a lung disease?'
Why do men suffer from sarcoidosis earlier than women?
IPF: promising new possibilities might offer help with deadly disease
King’s Sarcoidosis Questionnaire translated into Dutch
'Complement IPF guidelines with clinical expertise'
Did you know that international collaboration is of immense importance in the field of healthcare? By working together, different countries can help each other in optimizing specific aspects of medicine. A good example of this is the recent Dutch translation of an English sarcoidosis questionnaire. By translating the questionnaire, the Dutch researchers contributed to the availability of this important document.
It's important to assess the well-being of patients
Sarcoidosis is a systemic inflammatory disease that can affect any organ, but is most often (at least partly) localized in the lungs. In sarcoidosis, abnormal collections of inflammatory cells form lumps in the lungs, which makes it difficult to breath. With disease like sarcoidosis, it's important to assess the well-being of patients my measuring the 'quality of life' (QOL). By measuring the QOL, doctors and researchers can get an idea of the way a disease is affecting someone's life. The outcomes of QOL-tests can be used for example to compare different treatments, or to investigate how patients respond to different forms of medication.
Until now the KSQ questionnaire was not available in languages other than English. Therefore, Mirjam van Manen (University Medical Center, Rotterdam, The Netherlands) and colleagues translated the questionnaire from English to Dutch following international guidelines.
During translation in Dutch and in the patient interviews, there was no major cultural difference noted and the questionnaire was considered comprehensible and relevant by Dutch patients. The KSQ was also validated in a Dutch cohort by the researchers. Their study demonstrates a good construct validity of the Dutch KSQ General Health Status module against another QOL-questionnaire, called the 'WHO Quality of Life-BREF questionnaire'. The researchers think that the availability of the KSQ in other languages could facilitate international collaboration aiming at measuring, comparing and improving health status in patients with sarcoidosis.
Reference
Van Manen MJG, Wapenaar M, Strookappe B, et al. Validation of the King’s Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population. Vasc Diffuse Lung Dis 2016; 33: 75-82)
Acid reflux and idiopathic pulmonary fibrosis: the search for definitive answers
ILD and lung cancer: an unfortunate combination of events
Urgent need for action to prevent ILD caused by marine engines
Non-quartz part of coal might turn the coalminer's lungs to black
‘Lung on a chip’: the solution for testing lung-medicine?
Antifibrotics may help IPF patients waiting for a lung transplantation
IPF: the importance of early identification and a multidisciplinary approach
Sarcoidosis: a riddle to unfold
Improving palliative care for IPF patients
'Protect roadworkers against lung damage from asphalt fumes'
'Support the people that support the patients'
'Why keep smoking when you suffer from a lung disease?'
Why do men suffer from sarcoidosis earlier than women?
IPF: promising new possibilities might offer help with deadly disease
'Complement IPF guidelines with clinical expertise'